Jeff Cislini is CLO at Revolution Medicines, Inc. (RVMD). They have made 2 open-market trades across 1 company since 2023, most recently 2026-09-25.
CIK 0001969082
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| RVMD | 51,776 | $9.2M |
Shares reported on the most recent Form 4, priced at the 2026-09-29 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RVMD | SELL · 10b5-1 | 2026-09-25 | 2026-09-29 | $207.32 | $159K | -7.7% | — | — |
| RVMD | SELL · 10b5-1 | 2026-09-16 | 2026-09-18 | $199.24 | $671K | +6.8% | — | — |
| RVMD | SELL · 10b5-1 | 2026-08-21 | 2026-08-25 | $209.24 | $11.9M | +0.3% | -4.6% | — |
| RVMD | SELL · 10b5-1 | 2026-06-16 | 2026-06-18 | $156.12 | $337K | +15.5% | +11.1% | +20.8% |
| RVMD | SELL · 10b5-1 | 2026-03-17 | 2026-03-19 | $98.98 | $470K | -0.7% | +49.3% | +61.1% |
| RVMD | SELL · 10b5-1 | 2026-01-21 | 2026-01-23 | $115.60 | $105K | +3.2% | +10.9% | +43.8% |
| RVMD | SELL · 10b5-1 | 2025-12-16 | 2025-12-18 | $76.82 | $413K | +2.7% | +49.8% | +26.5% |
| RVMD | SELL · 10b5-1 | 2025-11-18 | 2025-11-20 | $70.14 | $1.9M | +10.9% | +15.0% | +42.4% |
| RVMD | SELL · 10b5-1 | 2025-10-17 | 2025-10-20 | $55.00 | $660K | +7.5% | +28.8% | +112.2% |
| RVMD | SELL · 10b5-1 | 2025-09-24 | 2025-09-26 | $44.26 | $159K | +8.6% | +31.6% | +83.3% |
| RVMD | SELL · 10b5-1 | 2025-09-16 | 2025-09-18 | $45.82 | $171K | +2.6% | +18.7% | +68.6% |
| RVMD | SELL · 10b5-1 | 2025-06-20 | 2025-06-23 | $39.61 | $151K | -1.5% | -2.4% | +15.5% |
| RVMD | SELL · 10b5-1 | 2025-06-16 | 2025-06-18 | $39.83 | $150K | -7.8% | -4.2% | +11.8% |
| RVMD | SELL · 10b5-1 | 2025-03-20 | 2025-03-24 | $38.71 | $158K | -15.8% | -4.1% | +2.6% |
| RVMD | SELL · 10b5-1 | 2025-03-17 | 2025-03-19 | $39.04 | $114K | -7.4% | -4.2% | +2.5% |
| RVMD | SELL · 10b5-1 | 2025-01-21 | 2025-01-22 | $40.50 | $97K | +4.0% | +2.0% | -9.1% |
| RVMD | SELL · 10b5-1 | 2024-12-16 | 2024-12-18 | $45.40 | $145K | +1.0% | -7.0% | -11.9% |
| RVMD | SELL · 10b5-1 | 2024-11-15 | 2024-11-19 | $55.13 | $282K | -7.9% | -23.0% | -26.3% |
| RVMD | SELL · 10b5-1 | 2024-11-06 | 2024-11-08 | $60.00 | $360K | -7.1% | -23.4% | -29.1% |
| RVMD | SELL · 10b5-1 | 2024-10-11 | 2024-10-15 | $50.17 | $301K | -5.3% | +17.1% | -13.1% |
| RVMD | SELL · 10b5-1 | 2024-09-16 | 2024-09-18 | $44.19 | $129K | -0.2% | +11.0% | -0.6% |
| RVMD | SELL · 10b5-1 | 2024-07-09 | 2024-07-10 | $40.83 | $196K | +10.2% | -1.4% | +14.4% |
| RVMD | SELL · 10b5-1 | 2024-06-26 | 2024-06-27 | $38.47 | $77K | +10.8% | +19.8% | +17.1% |
| RVMD | SELL · 10b5-1 | 2024-06-17 | 2024-06-20 | $37.39 | $131K | -0.6% | +27.5% | +17.2% |
| RVMD | SELL · 10b5-1 | 2024-05-21 | 2024-05-22 | $39.12 | $59K | -0.2% | -4.2% | +8.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.